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Abstract
Background: Pregnancy-associated malaria (PAM) is caused by Plasmodium falciparum-infected erythrocytes that
can sequester in placental intervillous space by expressing particular variant surface antigens (VSA) that can
mediate adhesion to chondroitin sulfate A (CSA) in vitro. IgG antibodies with specificity for the VSA expressed by
these parasites (VSAPAM) are associated with protection from maternal anaemia, prematurity and low birth
weight, which is the greatest risk factor for death in the first month of life.
Methods: In this study, the development of anti-VSAPAM antibodies in a group of 151 women who presented to
the maternity ward of Albert Schweitzer Hospital in Lambaréné, Gabon for delivery was analysed using flow
cytometry assays. Plasma samples from placenta infected primiparous women were also investigated for their
capacity to inhibit parasite binding to CSA in vitro.
Results: In the study cohort, primiparous as well as secundiparous women had the greatest risk of infection at
delivery as well as during pregnancy. Primiparous women with infected placentas at delivery showed higher levels
of VSAPAM-specific IgG compared to women who had no malaria infections at delivery. Placental isolates of
Gabonese and Senegalese origin tested on plasma samples from Gabon showed parity dependency and gender
specificity patterns. There was a significant correlation of plasma reactivity as measured by flow cytometry
between different placental isolates. In the plasma of infected primiparous women, VSAPAM-specific IgG measured
by flow cytometry could be correlated with anti-adhesion antibodies measured by the inhibition of CSA binding.
Conclusion: Recognition of placental parasites shows a parity- and sex- dependent pattern, like that previously
observed in laboratory strains selected to bind to CSA. Placental infections at delivery in primiparous women
appear to be sufficient to induce functional antibodies which can both recognize the surface of the infected
erythrocytes as well as block their binding to CSA. The correlation between serum reactivities of placental field
isolates from different geographic locations and collected at different times is indicative of the conserved nature
of the antigen(s) mediating PAM.
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Background
Adults living in malaria endemic areas have normally
been exposed to repeated infections with Plasmodium fal-
ciparum and are, therefore, clinically immune to the dis-
ease [1,2]. However, this is not true in the case of pregnant
women and the disease is more pronounced in primi-
gravid women than in multigravidas. Pregnancy associ-
ated malaria (PAM) may be accompanied by maternal
anaemia, abortion, stillbirth, prematurity, intrauterine
growth retardation and low birth weight, this being the
greatest risk factor for death in the first month of life [3].
It is now known that malaria-infected individuals living in
endemic areas accumulate a broad spectrum of protective
antibodies directed against variant surface antigens
(VSAs) present on infected erythrocytes (IEs) [4,5]. Fur-
ther studies show that agglutinating antibodies are princi-
pally directed against the major surface antigen P.
falciparum  erythrocyte membrane protein 1 (PfEMP-1)
[4,6]. Severity of malaria is related to the capacity of the P.
falciparum IEs to cytoadhere and to sequester in the micro-
vascular capillaries of vital organs [7].
In pregnant women, the placenta provides a new oppor-
tunity for the selective accumulation of P. falciparum IEs
[8]. IEs appear to express a different PfEMP-1 molecule
capable of interacting with chondroitin sulfate A (CSA), a
glycosaminoglycan (GAG) in the placental intervillous
space [8]. Other potential receptor molecules in the pla-
centa, such as hyaluronic acid and non-immune immu-
noglobulin G, are also known to interact with IEs [9,10].
Anti-VSA antibodies accumulate with each pregnancy and
protect the mother from placental malaria in subsequent
pregnancies [11,12]. The targets of these antibodies are
thought to be generated in a strain-independent manner,
with the capacity of recognizing parasites from different
geographic locations. The panreactive anti-CSA binding
antibodies also react with the surface of IEs in a sex-spe-
cific manner, such that serum samples from malaria-
exposed males do not show any reactivities toward IE sur-
face [13,14]. In one study, in which placental isolates were
used, it was shown that primigravid women lacked anti-
bodies that were capable of inhibiting the adhesion of IEs
to CSA [13], whereas in a second study where they used a
parasite selected on CSA, a significant level of anti-adhe-
sion antibodies was detected in primiparous women
whose placentas were found to carry malaria infections at
delivery [15]. Agglutinating antibodies were also detected
in primiparous women presented with infected placentas
but were not correlated with their capacity to inhibit CSA
adhesion [16]. In another study, significant association
between CSA-adhesion inhibitory antibodies and aggluti-
nation antibodies was reported, but many samples were
found to differ in their quality, on the one hand in
strongly inhibiting adhesion, but on the other in being
negative or only weakly positive in agglutination [17].
In addition to agglutination and anti-adhesion assays,
flow cytometric analysis has also been used successfully to
detect antibodies in sera from pregnant women directed
against the surface of P. falciparum IEs, previously selected
to bind CSA [14]. Here we describe the detection of VSA-
PAM-specific IgG in the plasma of a group of pregnant
women by flow cytometry using a panel of placental par-
asites. Antibody reactivities were assessed relative to parity
and gender, comparing infection rates of women with dif-
ferent parities. Antibody levels with respect to malaria
infections during the course of a pregnancy were also ana-
lysed. To gain an insight into the nature of these antibod-
ies, we also sought to determine whether VSAPAM-specific
IgG measured in flow cytometry can block parasite bind-
ing to CSA.
Materials and Methods
Study participants
One hundred and fifty-one women presented at the
maternity ward of the Albert Schweitzer Hospital in Lam-
baréné, Gabon for delivery between May and October
2002. Whenever possible, demographic data (e.g. ethnic
group, date of birth, weight) were collected from the study
participants upon admission. For those attending prenatal
care, information regarding malaria infections during the
course of pregnancy were taken from the maternity record
book, which documented peripheral parasitemia by thick
blood smears. Written informed consents were obtained
from all of the women and the study was approved by the
ethics committee of the International Foundation of the
hospital.
Blood samples
Peripheral blood was collected from the study partici-
pants within one hour after delivery in an EDTA-contain-
ing monovette and used in thick blood smears to
determine parasite densities. Giemsa-stained slides were
examined by light microscopy covering 100 fields with
the l00× objective under oil immersion and parasite den-
sities were recorded [18]. Peripheral blood samples were
then centrifuged (2,000 × g for 10 min) to obtain the
plasma and used in flow cytometric assays.
Blood was also extracted directly from the placenta. This
was done by excising a block of placental tissue (2 cm3)
from the maternal side of the placenta, placing it into a 50
ml falcon tube containing 25 ml of RPMI 1640 medium
and leaving it to drain on a horizontal rotator for about 10
min. Thereafter, the tissue block was squeezed with a pair
of forceps and removed from the tube. The remaining
solution was centrifuged (2000 × g for 10 min) and theMalaria Journal 2004, 3:21 http://www.malariajournal.com/content/3/1/21
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pellet was examined for the presence of malaria parasites
by conventional microscopy, as described above.
Placental parasite isolation
Placental blood for subsequent parasite culture was
extracted from thick blood smear positive placentas. First,
several one-centimeter deep incisions in the mother side
of the placenta were made and blood was withdrawn into
an EDTA syringe (monovette without needle). Gentle
squeezing of the placenta was found to help increase the
blood volume. Typically, three to six mls of blood were
obtained. Leucocytes were removed by Ficoll treatment
and the remaining cells were washed twice in RPMI 1640
medium. The cell pellet was resuspended to 5 % haemat-
ocrit in RPMI 1640 medium supplemented with 0.5 %
Albumax II, 2 % human serum and 200 µM hypoxanthine
and placed in a tissue culture flask at 37°C in a candle jar.
Parasitized erythrocytes were left to grow for one or two
cycles until the early ring stage before freezing. Parasites
were frozen in several aliquots using the Glycerolyte
method and thawed using the 1.6 % and 12 % NaCl
method [19]. Parasite CSA adhesion phenotype usually
diminished after about four weeks of continuous culture.
Consequently, enrichment of the phenotype on CSA was
performed every three weeks to maintain high levels of
binding to CSA [20].
Placental isolates used in this work were taken from two
different study cohorts, two parasites (Gb337 and Gb218)
from Lambaréné, as previously described [21] and two
parasites (vip43 and vip42) from Senegal. In Senegal, the
study took place in Pikine-Guédiawaye, located 15 km
north-east of Dakar, where malaria is hypoendemic with
an average of one infectious bite/person/year. Malaria
transmission is highly seasonal during the rains, from
September to January [22]. The study took place in the
maternity wards of the Centre de Santé Roi Baudoin de
Guédiawaye with nearly 7,000 childbirths per year. Preg-
nant women were enrolled after informed consent was
obtained in the delivery room from October 2001 to
March 2002. This study was approved by the National
Ethics Committee of the Senegalese Health Ministry. To
allow the identification of women with malarial infection,
an immunochromatographic test (ICT) [Sarachim,
Lausanne, Switzerland] was performed on finger pricked
capillary blood before delivery. Those presenting with an
infection were enrolled. The placenta was collected at
delivery for parasite isolation and a placental thick blood
smear was made for microscope examination [23].
Flow cytometry assays
The plasma samples from our study cohort were exam-
ined by flow cytometry for recognition of specific antigens
localized on the surface of IEs, as described previously
[24]. Plasma samples from five nulligravid women and
from seven males living in the same endemic area served
as controls. Late-stage IEs were enriched by magnet-acti-
vated cell sorting (MACS), diluted to approximately 2 ×
l06 IEs/ml in PBS-2% FCS, and stained with 2 µg/ml of
ethidium bromide. The suspension (100 µl) was mixed
with 5 µl of human plasma and incubated at 4°C for 30
min. Cells were washed twice each with 3 ml of PBS-2%
FCS. Subsequently, cells were stained with two layers of
antibodies, first with a goat anti-human IgG (diluted at
1:250), followed by a fluorescein isothiocyanate (FITC)-
conjugated rabbit anti-goat Ig (diluted at 1:25), with a
washing step between each antibody incubation, as
described above. Bound human IgG was quantified and
expressed as the mean FITC fluorescence intensity (MFI)
of ethidium bromide-gated IEs using a FACSCAN flow
cytometer.
Inhibition of binding assays
CSA binding plates (Falcon; catalogue no. 351016) were
prepared by drawing up to 10 circles of about 2 mm radius
on the plates using a Dakocytomation pen. Two of the 10
spots on each plate served as control, where no plasma
was added. In this way, up to four different plasma sam-
ples in duplicate can be tested on one plate at any one
time. The procedure was carried out by adding 7 µl of a
CSA solution (100 µg/ml dissolved in PBS) to the middle
of each circle and the plates were kept moist by leaving the
lid on and left at room temperature for one hour. The CSA
solution was aspirated from each circle and free protein-
binding sites were blocked for 30 min using a PBS-1% BSA
solution. Plates prepared in this way were used immedi-
ately. Binding inhibition assays were performed as fol-
lows: late-stage IEs were enriched by MACS, 5 µl of human
plasma were added to 100 µl of approximately 107 IEs/ml
diluted in PBS-2% BSA, and incubated for one hour at
37°C. Ten µl of the cell suspension were placed on the
CSA spot and incubation continued for another hour at
37°C in a humid incubator. The plates were washed twice
in the presence of PBS and the bound cells were fixed with
2 % glutaraldehyde for 30 min and stained with Giemsa.
The number of bound cells per mm2 was counted under
the light microscope at low power and the average of 4
counts was taken as the number of bound cells/mm2.
Statistical analysis and data presentation
Groupwise medians were compared by Wilcoxon rank test
(for two groups) and Kruskal-Wallis one-way analysis of
variance (for more than two groups). Spearman's test (rs)
was used for analysis of parameter association.
Results
Comparison of placental parasitemia by thick blood smear
From the group of 151 women enrolled in the study, 41
were categorized as primiparous women, 23 were secun-
diparous women and 87 were multiparous women. ThickMalaria Journal 2004, 3:21 http://www.malariajournal.com/content/3/1/21
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blood smear analysis of their placental blood showed that
11% of the study participants were infected at delivery,
with the primiparous and secundiparous women showing
higher infection rates (20% and 17%, respectively), com-
pared to multiparous women (7%) (Table 1). A compari-
son was also made between the presence of infections at
the time of delivery and during the course of the preg-
nancy. In the primiparous group, nine women had
peripheral parasitaemia during their pregnancies, whereas
two women were infected both at delivery and during
their pregnancies. The risk for a woman pregnant for the
first time to be infected during her pregnancy and at deliv-
ery was higher than the similar risk for a woman in her
further pregnancies. This conclusion is supported by the
observation that in the secundi- and multiparous groups,
no woman who was infected at any time during the entire
period of pregnancy was also infected at delivery.
To further analyse placental infection rates in our study
participants at the time of delivery via thick blood smears,
the cohort was divided into two groups, one consisting of
women who had given birth once and the other consisting
of women who had ≥ 2 deliveries. Surprisingly, the com-
parison showed on significant difference between the two
groups (Pearson Chi square test). However, when primi-
parous women and secundiparous women were grouped
together as pauciparous women and compared to those
who had ≥ 3 deliveries, it was interesting to observe that
the former group had a significantly higher infections rate.
Consequently, all further analyses made in this study took
into consideration comparisons not only between primi-
and multiparous women but also comparisons between
pauci- and multigravids.
Infection rates of women with documented malaria during 
pregnancy
In this analysis, it was also noted whether the recruited
women had previous malaria infections during the course
of their pregnancies, as opposed to the previous compari-
son whereby they were blood smear positive at the time of
delivery. Unlike the results of the first comparison, where
no significant difference was found in infection rates as
determined at the time of delivery between primi- and
multiparous women, this time the former group was in
fact found to be significantly more infected than the latter
group, when analysed for the presence of malarial infec-
tions during pregnancy (P = 0.02). There was also a signif-
icantly higher rate of infection in pauciparous women
during pregnancy than in multiparous women (P =
0.006).
Recognition of variant surface antigens by flow cytometry
Placental isolates from two Gabonese (Gb337 and
Gb218) and two Senegalese (vip43 and vip42) patients
were used in flow cytometric assays to assess the level of
VSAPAM-specific IgG in the plasma of the 151 women
recruited in this study as well as plasma from five control
nulligravid women and seven males. Antibody reactivity
was recorded as the mean fluorescent intensity (MFI) of
the ethidium bromide positive cells determined in the
assay. The parity of the 151 women ranged from 1–14
and, due to the low number of women with high parities,
those with seven or more parities were grouped with the
sixth parity group for statistical analysis purposes. The lev-
els of antibodies recognizing placental isolates were found
to correlate with parity (Figure 1). A Kruskal-Wallis non-
parametric one-way analysis of variance was further
applied to the data and has shown that there are differ-
ences among the medians of all six groups (P = 0.003). It
was observed also that the mean rank score values in the
test in all the parity groups (from the third birth upwards)
were significantly higher when compared to the value in
the primigravid group, but this was not the case when
compared to the secundigravid group. These patterns were
consistent with all four parasites tested.
On the other hand, plasma samples from women who
had not had children were not reactive. In addition, sex-
specific recognition of the placental isolates was also
observed in the plasma from the 151 women, since male
control samples also showed no recognition. The plasma
samples correlated in their capacities to recognize surface
antigens expressed on erythrocytes infected with different
field isolates. The comparison was made based on MFI
values after subtracting the mean + 2 standard deviations
of the MFI values calculated from the nulli and male
plasma samples. This value was calculated for each para-
site isolate for each flow cytometric assay and all values
were highly reproducible (MFI range between 30 and 60)
in three independent experiment for each isolate. For all
Table 1: Placental thick blood smear results and documented peripheral parasitaemia during pregnancy data of women included in the 
study
Parity Placenta positive at delivery Peripheral blood positive during pregnancy Double postive
Primiparous (n = 41) 8 (20 %) 9 2
Secundiparous (n = 23) 4 (17 %) 4 0
Multiparous (n = 87) 6 (7 %) 5 0Malaria Journal 2004, 3:21 http://www.malariajournal.com/content/3/1/21
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the pairs of parasite isolates, the levels of VSAPAM-specific
plasma IgG correlated, even though for certain pairs of
comparison (such as that between parasite isolates Gb337
and vip42 or Gb337 and vip43) the correlation was less
tight than for others (Fig. 2) (see discussion). Neverthe-
less, the level of correlation of plasma reactivity between
different placental isolates is sufficiently significant to sug-
gest a common nature of surface antigens expressed on
infected erythrocytes causing PAM.
The effect of P. falciparum positive placentas on the levels
of recognition was also investigated. Plasma taken from
women of the primiparous group whose placentas were
infected had higher levels of antibodies than plasma from
women from the same group whose placentas were not
infected, as shown for one parasite Gb337 (Fig. 3, panel
A). The same pattern was observed for plasma taken from
the pauciparous women (panel C). On the other hand,
this was not found to be the case for the multiparous
Parity dependence of recognition of variant surface antigens on four placental parasite isolates by VSAPAM-specific IgG in plasma  obtained from 151 women at delivery from an area of hyperendemic malaria transmission (Lambaréné, Gabon) Figure 1
Parity dependence of recognition of variant surface antigens on four placental parasite isolates by VSAPAM-specific IgG in plasma 
obtained from 151 women at delivery from an area of hyperendemic malaria transmission (Lambaréné, Gabon). Parasite isolate 
and the corresponding statistical significance of the correlation between parity and mean fluorescence intensity are shown. The 
fit line using least squares regression is shown for each relationship.
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group (panels B and D). Here, women who have been
pregnant more than twice generally have high antibody
levels. For three out of the four parasites that were ana-
lysed in this study, similar patterns were observed. P val-
ues for the comparisons are given in Table 2.
The level of anti-VSA antibodies was compared in pau-
ciparous women between those who had infected pla-
centa at delivery and women with positive thick blood
smear during pregnancy but with negative placenta at
delivery. In the latter category, it was observed that their
anti-VSA antibodies generally appeared to be lower for
some of the tested isolates. P values of the statistical com-
parisons were 0.03 for Gb337, 0.05 for vip43, 0.08 for
Gb218 and 0.35 for vip42. The same comparison made
for primiparous women showed no difference.
Inhibition of binding assays
Based on the observation that some primiparous women
have high levels of VSAPAM-specific IgG as measured in
flow cytometry, an effort was made to determine whether
the antibodies found in this population of primiparous
women, who also carried malaria positive placentas could
provide some protection against malarial infections, for
example by limiting parasite accumulation in the pla-
centa. The capacity of these antibodies to inhibit the bind-
ing of erythrocytes infected with placenta parasites to CSA
was therefore evaluated, CSA being the main receptor
molecule on the syncytiotrophoblast cells lining the pla-
centa implicated in PAM. Eight plasma samples of pla-
centa positive women which exhibited high levels of
recognition in flow cytometry were selected for analysis. A
comparison of their MFI levels with their anti-adhesion
capacities showed that six out of the eight plasma samples
analysed also had high levels of anti-adhesion antibodies
and were able to inhibit binding to CSA by 86 – 96 %,
Relationship of anti-VSA levels between different placental isolates Figure 2
Relationship of anti-VSA levels between different placental isolates. Anti-VSA levels were measured as mean fluorescence 
intensity (MFI). Spearman rank correlation coefficients together with their strengths are given for each parasite pair. The fit line 
using least squares regression is shown for each comparison.
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based on results of experiments carried out with placental
parasite vip43 (Figure 4). Thus, the presence of malarial
infection was observed to induce high levels of VSAPAM-
specific IgG in primiparous women. The correlation
between levels of anti-PAM antibodies measured by flow
cytometry and the anti-adhesion capacities of these anti-
bodies implies a link between functional and antigenic
domains.
Discussion
The observation that the rates of placental infections at
delivery are similar between the primi-and secundigravid
women in this area (Table 1) demonstrates that women in
their second pregnancies are almost as susceptible to
malarial infections as those who are pregnant for the first
time. This result is in keeping with previously published
work [25,26]. Another notable finding is that the
Effect of placental infections as determined by thick blood smears on the level of anti-VSA antibodies Figure 3
Effect of placental infections as determined by thick blood smears on the level of anti-VSA antibodies. The MFIs of plasma were 
obtained and compared between women who presented with positive and negative placentas in (A) primiparous women and 
(B) multiparous women (≥ 2). The same comparisons was made between positive and negative placentas in (C) pauciparous 
women and (D) multiparous women (≥ 3). The data showed here were performed on the parasite Gb337. P values for each 
comparison are indicated in the graphs and the grand means of all MFI values for each group are shown as dashed lines. The 
center line in each diamond shows the group mean, and the vertical spans of the diamond show the 95% confidence interval.
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Table 2: Comparison of MFI levels of plasma from women with non-infected and infected placentas at delivery within each group using 
Wilcoxon rank test
Mean rank score of non-infected/infected placentas (P-value)
Placental parasite Primiparous women Multiparous women ≥ 2 Pauciparous women Multiparous women ≥ 3
Gb337 18/29 (0.02) 54/71 (0.1) 30/45 (0.009) 43/59 (0.12)
Vip43 19/28 (0.04) 54/67 (0.2) 30/44 (0.01) 43/59 (0.12)
Gb218 19/29 (0.04) 53/72 (0.07) 29/42 (0.04) 43/62 (0.07)
Vip42 18/26 (0.08) 52/68 (0.1) 28/39 (0.07) 42/60 (0.08)
Comparison of antibody levels in surface recognition and CSA biding Figure 4
Comparison of antibody levels in surface recognition and CSA biding. CSA adhesion activities (■ ) and the corresponding anti-
VSA levels () measured as mean fluorescent intensities of plasma obtained from primiparous women presented with infected 
placentas are shown. High CSA binding also stands for low anti-CSA adhesion activity. Plasma samples from a semi-immune 
nulligravid woman and a male served as controls.
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percentage of primigravid women who are infected at
delivery is not significantly higher than multigravid
women, which could be due to differences in malaria
transmission intensities in different study areas. The
observed lack of significance is probably not solely due to
the small sample size, since significance was achieved
when primi- and secundigravid women were grouped
together and compared to multigravids. In the study area,
only 22 % of the primiparous women were infected at
delivery, whereas in other areas, higher infection rates at
first pregnancies have been reported, for example 38 % in
Kisumu, Kenya [27] and 34–40 % in Shire Valley, Malawi
[28].
However, when another parameter was investigated,
namely the presence of malarial infections during preg-
nancy, there was a significantly higher percentage of prim-
igravids who were infected compared to multigravids.
Such an observation may be attributed to the time factor
during data collection. While data collected at delivery is
restricted to one point in time, that collected during preg-
nancy is accumulated over several months. Thus, those
primigravid women who did not carry malarial infections
at delivery, but who could have been infected during their
pregnancies, would not have been included in this group.
On the other hand, the chance of detecting an infection
given a longer time span is simply higher.
The data of this work were generated using placental par-
asites collected from two different study areas and plasma
samples collected from women delivering in Lambaréné.
The parity-dependent pattern of recognition by plasma
samples collected from pregnant women using placental
isolates was not as obvious as that observed for laboratory
parasite strains selected for CSA binding [14]. The reason
may be that placental parasites appear to be less well rec-
ognized than CSA-selected parasites. Host factor may also
play a role in recognition pattern differences thus it may
be that immunity develops more slowly in Gabon due to
low exposure. The results described here show that
women in their second pregnancies still presented with
low levels of anti-VSA antibodies which, in terms of their
measured MFI levels were not significantly different from
that measured in the primiparous group (Fig. 1). How-
ever, the levels of antibodies recognizing the surface of IEs
were observed to increase significantly only from the third
parity upwards, in comparison to the primigravid women.
Since MFI obtained in the secundigravid group was not
significantly higher than the primigravid group, it rein-
forces the observation that secundiparous women are
probably as susceptible to malarial infection as the prim-
igravid group. In this case, the grouping of secundiparous
women with multiparous women is likely to skew the
data.
Good correlation was observed between different pla-
centa parasite isolates and their recognition by plasma
samples from women of different parities (Fig. 2), indicat-
ing that the plasma antibodies are targeting the same fam-
ily of antigens [29] responsible for placental malaria on
infected erythrocytes. The less firm correlation between
the parasite isolates Gb337 and vip42 or vip43 compared
with other parasite pairs could be because the parasites
were assayed against Gabonese sera, and Gb337 parasite
is a Gabonese parasite while vip42 and vip43 are of
Senegalese origin. However, difference in geographic ori-
gin alone may not sufficiently explain the variations in the
correlation coefficients between Gb337/vip42 and
Gb337/vip43 pairs and the rest of the comparisons, par-
ticularly since Gb218/vip42 and Gb218/vip43 yield a dif-
ferent picture. It is likely that Gb337 in being the most
recognized parasite amongst the four parasites studied has
shaped the recognition pattern and the variations
observed are thus an isolate-specific phenomenon.
When data were segregated into whether placentas were
infected or not at delivery and analysed as a function of
parity (Fig. 3 and Table 2), it was obvious that sera from
primiparous women with malaria-positive placenta had
significantly higher mean MFI than those with negative
placentas. Anti-VSA antibodies in the susceptible women
(pauciparous), who were infected during pregnancy and
negative at delivery, could be shorter-lived antibodies
than in multiparous women. This could be explained by
the possibility that multiparous women by being
pregnant more often risk continuous exposure to infec-
tion and hence repeated boosting that could lead to an
accumulation of memory against VSAs. This would in turn
trigger a quick immune response following infection,
resulting in an overall higher level of these antibodies (not
apparent in primiparous women). Multiparous women
therefore exhibited higher levels of anti-VSA antibodies
regardless of whether the placenta infected or not. Beeson
et al [17] reported very similar findings in which VSAPAM
specific IgGs were more prevalent in infected than unin-
fected primigravidae and their levels did not differ in
infected and uninfected multigravidae. In an earlier study,
Ricke et al [14] showed that a considerable number of
primiparous women presented high levels of anti-VSA
antibodies, but this was not correlated with placental
infections, as samples were collected from the participants
at their third-trimester. Other studies have also shown
that all women, regardless of parity, produced VSAPAM-
specific IgG, determined as anti-CSA adhesion antibodies
[15,30], contrary to the findings of Fried et al [13]. The lat-
ter showed that plasma from primigravid women, unlike
that of multigravid women had little anti-adhesion anti-
bodies against CSA-binding parasites. Such discordant
findings may be explained by the use of different plasma
dilutions or the setting of different cut-off values. In ourMalaria Journal 2004, 3:21 http://www.malariajournal.com/content/3/1/21
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hands, plasma of primiparous malaria-infected women
containing high anti-VSA antibodies were also capable of
inhibiting the binding of placental parasites to CSA (Fig.
4). Beeson et al [17] have postulated that CSA-adhesion
inhibitory antibodies and anti-VSA antibodies may be
acquired independently during infection and have differ-
ent roles in immunity. Results from our study based on
isolate vip43 would suggest that the surface of erythro-
cytes infected with it simultaneously express overlapping
functional and antigenic domains. The identification of
functional antibodies which appear to inhibit the binding
of parasites to CSA in the placenta is crucial to developing
a successful vaccination strategy against PAM.
Conclusion
The results indicate that pauciparous women from the
study area are more infected at delivery than multiparous
women. Recognition of placental parasites shows a simi-
lar parity-dependency pattern, which is highly suggestive
of the common nature of surface antigens expressed on
IEs causing PAM. Primiparous women infected at delivery
appear to carry antibodies capable of recognizing the sur-
face of IEs and blocking their binding to CSA. The obser-
vation that pauciparous women with positive thick blood
smear during pregnancy but with negative placenta at
delivery carried lower levels of anti-VSA can be explained
by the short life span of the induced antibodies. The find-
ing of a correlation between serum reactivities of different
placental field isolates would indicate that the parasite lig-
ands on the surface of IEs involved in CSA binding and
causing PAM are most likely to represent functionally con-
served molecules of a distinct subfamily.
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